Detalhe da pesquisa
1.
Drug repurposing for cancer therapy, easier said than done.
Semin Cancer Biol
; 68: 123-131, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31877340
2.
Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal.
Clin Transl Oncol
; 26(5): 1077-1088, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38064014
3.
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?
Clin Drug Investig
; 43(4): 227-239, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36884210
4.
PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal.
Curr Med Chem
; 2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287286
5.
BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal.
Curr Mol Pharmacol
; 15(6): 815-831, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620071
6.
Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications.
Curr Cancer Drug Targets
; 22(9): 703-716, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35422220
7.
Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
Pharmacogenet Genomics
; 21(12): 894-901, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21946899
8.
Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial.
Ann Hematol
; 90(4): 379-87, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20922525
9.
Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico.
Ther Innov Regul Sci
; 54(2): 342-352, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072574
10.
Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer.
Med Oncol
; 26(2): 210-4, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19016011
11.
Pharmacodynamics of current and emerging treatments for cervical cancer.
Expert Opin Drug Metab Toxicol
; 15(8): 671-682, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340683
12.
Growth inhibition and transcriptional effects of ribavirin in lymphoma.
Oncol Rep
; 42(3): 1248-1256, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31322273
13.
The prince and the pauper. A tale of anticancer targeted agents.
Mol Cancer
; 7: 82, 2008 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-18947424
14.
Ivermectin as an inhibitor of cancer stemlike cells.
Mol Med Rep
; 17(2): 3397-3403, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29257278
15.
Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy.
Expert Opin Investig Drugs
; 27(5): 475-489, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29723075
16.
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.
Oncol Lett
; 13(3): 1905-1910, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28454342
17.
Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.
Cancer Cell Int
; 6: 22, 2006 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-17014709
18.
Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines.
Cancer Cell Int
; 6: 2, 2006 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-16448574
19.
The safety of drug treatments for cervical cancer.
Expert Opin Drug Saf
; 15(2): 169-80, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26650333
20.
Viral inhibitors of NKG2D ligands for tumor surveillance.
Expert Opin Ther Targets
; 20(11): 1375-1387, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27322108